Search Results

Displaying Results 3401-3425 of 26679 "'D'"

Aug 05, 2026, 21:50 ET Haier se asocia con AO 1 Point Slam para llevar el tenis de base al escenario de los Grand Slams

de productos y soluciones que satisfagan las necesidades cambiantes de los hogares en diversos mercados.Con una red global de I+D y capacidades de innovación localizadas, Haier crea soluciones para el hogar inteligente diseñadas en función de distintos entornos domésticos y estilos

More news about: Haier


Aug 05, 2026, 20:30 ET AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and Aging

working on innovative solutions, and venturing into novel drug delivery methods for better bioavailability.To fulfil the unmet needs, Insilico R&D set out to discover an innovative inhibitor, guided by the structure-based drug design (SBDD) approach with Chemistry42, Insilico's generative chemistry

More news about: Insilico Medicine


Aug 05, 2026, 20:00 ET Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China

and metabolic, ophthalmology, and other major diseases, announced that the first patient has been dosed in a pivotal study evaluating IBI363 (Takeda R&D code: TAK-928), a potential first-in-class PD-1/IL-2α-biased bispecific fusion protein, in combination with bevacizumab versus investigator's

More news about: Innovent Biologics


Aug 05, 2026, 19:51 ET Strathcona Resources Ltd. Reports Second Quarter 2026 Financial and Operating Results and Announces Quarterly Dividend

Company's new 8 well pair D01 West pad at Lindbergh, which achieved a peak rate of approximately 7,000 bbls / d at a steam-oil-ratio of less than 2.0x in late June. Taken together, the restored fuel gas supply and strong D01 West performance contributed to production of over 20 Mbbls / d from Lindbergh in June,

More news about: Strathcona Resources Ltd.


Aug 05, 2026, 19:00 ET Genesis MedTech Receives CE Mark Approval for 8 mm Video Endoscope

-- Genesis MedTech has received CE Mark approval for its latest 8 mm video endoscope, marking an important milestone in minimally invasive imaging. Achieving 3D imaging, 4K resolution and fluorescence capability in an 8 mm endoscope has been one of the key engineering challenges in advanced surgical visualisation.

More news about: Genesis MedTech Group


Aug 05, 2026, 17:28 ET Clarity Consultants Appoints Heidi Milberg as Executive Vice President of Growth and Client Services

project-based solutions, and managed learning services. For more than 30 years, organizations have relied on Clarity for flexible access to skilled L&D professionals, dependable project execution, and structured support for ongoing learning programs. Our model provides the talent, processes, and responsiveness

More news about: Clarity Consultants


Aug 05, 2026, 16:30 ET Riley Permian Reports Second Quarter 2026 Results

quarter ended June 30, 2026. SECOND QUARTER 2026 HIGHLIGHTS Reported 34.3 MBoe/d of total equivalent production (oil production of 21.2 MBbls/d)Generated $64 million of operating cash flow or $75 million before changes in working capital(1)

More news about: Riley Exploration Permian, Inc.


Aug 05, 2026, 16:15 ET SM Energy Reports Second Quarter 2026 Results

refund.GuidanceSM raised its second-half production outlook to 435–440 MBoe/d, including approximately 238 MBbl/d of oil, from 430 MBoe/d, and narrowed its full-year production guidance to 418–423 MBoe/d (223–225 MBbl/d of oil).SM reaffirmed its full-year capital guidance.See the

More news about: SM Energy Company


Aug 05, 2026, 16:15 ET Tronox Reports Second Quarter 2026 Financial Results

—Other (d)2

More news about: Tronox Holdings plc


Aug 05, 2026, 16:15 ET VIAVI Announces Fiscal Fourth Quarter and Fiscal Year 2026 Results

our industry and customer base; (d) competitive pressures; (e) unforeseen changes or deceleration in the demand for current and new products, technologies, services, delays or unforeseen events in the roll-out of new industry platforms or evolving technology such as 3D sensing and customer purchasing

More news about: VIAVI Financials


Aug 05, 2026, 16:15 ET Energy Fuels Announces Q2-2026 Results

729,282Qualified Person StatementThe scientific and technical information disclosed in this news release was reviewed and approved by Daniel D. Kapostasy, PG, Registered Member SME and Senior Vice President, Chief Technical Officer for the Company, who is a "Qualified Person" as defined in S-K

More news about: Energy Fuels Inc.


Aug 05, 2026, 16:12 ET Solventum Reports Second Quarter 2026 Financial Results

Purification and Filtration separation-related (d)

More news about: Solventum


Aug 05, 2026, 16:05 ET Western Midstream Announces Second-Quarter 2026 Results and Revised Full-year Guidance

throughput(5) averaged 5.3 Bcf/d, representing a 3-percent sequential-quarter increase. Second-quarter 2026 crude-oil and NGLs throughput(5) averaged 523 MBbls/d, a slight sequential-quarter increase. Second-quarter 2026 produced-water throughput(5) averaged 2,939 MBbls/d, representing a 5-percent

More news about: Western Midstream Partners, LP


Aug 05, 2026, 16:05 ET Envista Reports Second Quarter 2026 Results

Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the

More news about: Envista Holdings Corporation


Aug 05, 2026, 16:05 ET Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

marketable securities totaling $895.2 million, which is expected to provide cash runway into 2030.Research and development (R&D) expenses: R&D expenses were $29.0 million for the second quarter of 2026, compared to $21.5 million for the second quarter of 2025.General

More news about: Enliven Therapeutics, Inc.


Aug 05, 2026, 16:05 ET Kulicke & Soffa Reports Third Quarter 2026 Results

0.3D. Restructuring expenses

More news about: Kulicke & Soffa Industries, Inc.


Aug 05, 2026, 16:05 ET Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

(174,370)Deemed dividend from Series D redeemable convertible preferred stock—

More news about: Caris Life Sciences


Aug 05, 2026, 16:04 ET P&F Products & Features GmbH anuncia la adquisición de AVVie GmbH

mejorar la calidad de vida de los millones de personas afectadas es fundamental para la misión de P&F.Al combinar la infraestructura de I+D y la propiedad intelectual de AVVie con las capacidades globales de P&F en desarrollo de productos, asuntos clínicos y regulatorios, fabricación y

More news about: P&F Products & Features GmbH


Aug 05, 2026, 16:02 ET GRAIL Reports Second Quarter 2026 Financial Results

charge related to the deferred asset recognized in connection with the Samsung SPA in the current period and the in-process research and development ("IPR&D") impairment charge in the prior period. 

More news about: GRAIL, Inc.


Aug 05, 2026, 16:01 ET Axon reports Q2 2026 revenue of $904 million, up 35% year over year

compensation expense.SG&A expense of $291 million, or 32.2% of revenue, included $71 million in stock-based compensation expense.R&D expense of $209 million, or 23.1% of revenue, included $62 million in stock-based compensation expense.Net income of $29 million

More news about: Axon


Aug 05, 2026, 16:00 ET ASCENT RESOURCES REPORTS SECOND QUARTER 2026 OPERATING AND FINANCIAL RESULTS AND PROVIDES GUIDANCE UPDATE

Second Quarter Highlights:Net production averaged 2,194 mmcfe/d, with liquids production averaging over 52,000 bbls/dPre-hedge realization of $3.15 per mcfe, a $0.25 per mcfe premium to NYMEX natural gas pricesGenerated Cash Flow from Operations, Adjusted

More news about: Ascent Resources Utica Holdings, LLC


Aug 05, 2026, 16:00 ET BOA Acquisition Corp. II Announces Closing of $143.75 Million Initial Public Offering

telecommunications and transportation sectors.D. Boral Capital LLC acted as sole book-running manager for the offering.The public offering was made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained from D. Boral Capital LLC, 590 Madison Avenue, 39th

More news about: BOA Acquisition Corp. II


Aug 05, 2026, 15:56 ET ATLAS OCEAN VOYAGES UNVEILS ITS MOST EXPANSIVE EUROPE COLLECTION WITH 37 EPICUREAN & CULTURAL EXPEDITIONS FOR 2028

May 30, 2028 | 12 NightsD-Day Anniversary voyage commemorating one of history's defining moments with meaningful visits to Normandy.World Traveller |

More news about: Atlas Ocean Voyages


Aug 05, 2026, 15:53 ET INTCO Medical distinguée dans le « S&P Global Sustainability Yearbook » (édition chinoise) 2025 pour ses progrès en matière d'ESG

Cette distinction confirme les progrès constants que nous réalisons en matière d'ESG. Nous continuerons à intégrer le développement durable dans la R&D, la production, les opérations et la collaboration internationale afin de renforcer notre compétitivité à long terme et de créer de la valeur durable

More news about: INTCO Medical


Aug 05, 2026, 15:41 ET P&F Products & Features GmbH annonce l'acquisition d'AVVie GmbH

Plus de 13 millions de personnes en Europe et aux États-Unis souffrent d'une régurgitation mitrale d' , une affection caractérisée par un reflux sanguin vers l'oreillette gauche du cœur. Malgré l'ampleur du problème, seuls 5 % des patients atteints d'une

More news about: P&F Products & Features GmbH


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.